Roivant Sciences (ROIV) Debt to Equity (2021 - 2024)
Roivant Sciences' Debt to Equity history spans 4 years, with the latest figure at $0.01 for Q2 2024.
- For Q2 2024, Debt to Equity fell 85.88% year-over-year to $0.01; the TTM value through Jun 2024 reached $0.01, down 85.88%, while the annual FY2024 figure was $0.03, 75.07% down from the prior year.
- Debt to Equity reached $0.01 in Q2 2024 per ROIV's latest filing, down from $0.03 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.13 in Q3 2022 to a low of $0.01 in Q2 2024.
- Average Debt to Equity over 4 years is $0.06, with a median of $0.06 recorded in 2023.
- Peak YoY movement for Debt to Equity: soared 680.26% in 2023, then plummeted 85.88% in 2024.
- A 4-year view of Debt to Equity shows it stood at $0.09 in 2021, then tumbled by 44.46% to $0.05 in 2022, then plummeted by 34.44% to $0.03 in 2023, then crashed by 74.45% to $0.01 in 2024.
- Per Business Quant, the three most recent readings for ROIV's Debt to Equity are $0.01 (Q2 2024), $0.03 (Q1 2024), and $0.03 (Q4 2023).